2018
DOI: 10.1002/bit.26530
|View full text |Cite
|
Sign up to set email alerts
|

Toward industrial production of isoprenoids in Escherichia coli: Lessons learned from CRISPR‐Cas9 based optimization of a chromosomally integrated mevalonate pathway

Abstract: Escherichia coli has been the organism of choice for the production of different chemicals by engineering native and heterologous pathways. In the present study, we simultaneously address some of the main issues associated with E. coli as an industrial platform for isoprenoids, including an inability to grow on sucrose, a lack of endogenous control over toxic mevalonate (MVA) pathway intermediates, and the limited pathway engineering into the chromosome. As a proof of concept, we generated an E. coli DH1 strai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 68 publications
(126 reference statements)
1
31
0
Order By: Relevance
“…This decreases strain fitness and can ultimately lead to cellular death (Dahl et al 2013, George et al 2014, Alonso-Gutierrez et al 2017. DST3 is able to identify regions in the parameter space leading to metabolic imbalances and to provide clues to rectify these phenotypes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This decreases strain fitness and can ultimately lead to cellular death (Dahl et al 2013, George et al 2014, Alonso-Gutierrez et al 2017. DST3 is able to identify regions in the parameter space leading to metabolic imbalances and to provide clues to rectify these phenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…Imbalances are frequently encountered in the metabolism of engineered microbial strains (Dahl et al 2013, George et al 2014, Alonso-Gutierrez et al 2017) and in inborn metabolic diseases such as phenylketonuria (Levy 1999) and maple syrup urine disease (Haymond et al 1973), often by the excretion of some metabolite. Consider the simplest example of a metabolic pool as shown in Fig.…”
Section: Metabolic Imbalances Are Treated By Considering Knife-edge Cmentioning
confidence: 99%
“…The replacement of each of the native promoters with a strong promoter in the spectinabilin gene cluster from Streptomyces orinoci resulted in the successful activation of the spectinabilin pathway, as well as the improved production of spectinabilin in a heterologous host from an undetectable amount to a high level (Shao et al, ). Thus, the set of strong promoters, such as T7 (Alonso‐Gutierrez et al, ; Borgeaud & Blokesch, ; Studier & Moffatt, ), ParaB , PrhaB , PrhaS , Ptac , Psyn1 , or Psyn4 (Haldimann & Wanner, ), that are suitable for the RNA polymerase in different bacterial cell hosts can be changed to optimize expression levels. For instance, a set of insulated bacterial promoters (Davis, Rubin, & Sauer, ) has been designed for stimulatory or repressive effects, which are likely to be useful when designing expression cassette elements.…”
Section: Strategies For Optimizing Heterologous Gene Expression In Ementioning
confidence: 99%
“…In particular, they have enabled rapid, easy yet accurate construction of strains for some production platform microorganisms, e.g. Saccharomyces cerevisiae and Escherichia coli (15)(16)(17)(18), contributing significantly to the bio-based economy. For the bio-based economy, other alternative production microorganisms are also essentially required to generate sustainable alternatives for yielding green chemicals and biofuels from environmentally friendly resources, and become increasingly important.…”
Section: Introductionmentioning
confidence: 99%